Actively Recruiting
Comparing Remimazolam and Propofol for Anesthesia During Major Liver Surgery to Prevent Low Blood Pressure Under Low Central Venous Pressure Management
Led by Beijing Tsinghua Chang Gung Hospital · Updated on 2026-11-04
224
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether remimazolam is better than propofol at preventing low blood pressure during major liver surgery in adults. The study focuses on patients having planned removal of at least three liver segments. It is a randomized, controlled trial comparing these two drugs for maintaining anesthesia during surgery, aiming to reduce the depth and duration of low blood pressure. The research is sponsored by Beijing Tsinghua Chang Gung Hospital and involves 224 adults. Participants will receive a standard induction of anesthesia with etomidate, sufentanil, and cisatracurium, followed by maintenance with either remimazolam or propofol. The doses of each drug will be adjusted based on brain activity monitoring and clinical signs during surgery. Both groups will follow a low central venous pressure management protocol to reduce bleeding and manage hypotension. The assigned drug infusion will continue until the planned end of anesthesia emergence. During the study, participants will have continuous blood pressure monitoring and receive standard care if blood pressure drops. Researchers will track blood pressure levels during liver tissue removal and throughout anesthesia, plus use of blood pressure support medicines, blood loss, transfusions, recovery, organ complications, heart injury, and side effects. Follow-up will continue for 30 days after surgery to assess outcomes and safety.
CONDITIONS
Brief Title
Remimazolam Versus Propofol for Maintenance of Anaesthesia During Major Hepatectomy Under Low Central Venous Pressure
Research Team
Z
Zhifeng Gao, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here